Brain Scientific Inc. (BRSF)
OTCMKTS
· Delayed Price · Currency is USD
0.7500
-0.6500 (-46.43%)
Apr 25, 2025, 4:00 PM EDT
Brain Scientific Revenue
In the year 2022, Brain Scientific had annual revenue of $214.56K, down -19.26%. Brain Scientific had revenue of $5.08K in the quarter ending December 31, 2022, a decrease of -97.98%.
Revenue
214.56K
Revenue Growth
-19.26%
P/S Ratio
4.34
Revenue / Employee
19.51K
Employees
11
Market Cap
931.99K
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Silence Therapeutics | 43.26M |
Brain Scientific News
- 2 years ago - From Decibels to Dollars: Piezoelectric Materials Market to Flourish - GlobeNewsWire
- 2 years ago - Brainbox Validates NeuroCap(TM) In Testing Regimen; Adds Them to its Sports Medicine and Pharma Solutions - GlobeNewsWire
- 2 years ago - Brain Scientific Partners with SysteMedic, Receives First Purchase Order for NeuroCaps in Israel - GlobeNewsWire
- 2 years ago - Brain Scientific Signs Agreement with MVAP Medical Supplies to Go After Rapidly Growing Pediatric Neurodiagnostic Space - GlobeNewsWire
- 2 years ago - Brain Scientific Inks Deal with Fulcrum to Go After At-Home Diagnostic Space, Hires VP of Marketing and Communications - GlobeNewsWire
- 2 years ago - Brain Scientific Announces Release of Improved NeuroCap(TM) and New US Distribution Deal with D&D Medical - GlobeNewsWire
- 2 years ago - Daniel Cloutier, a Veteran Sales Executive, Joins Brain Scientific as Chief Revenue Officer - GlobeNewsWire
- 2 years ago - Brain Scientific Announces CE Mark Approval for NeuroCap™ Device - GlobeNewsWire